Lyndsay Fisher
Physician
Also affiliated: Arkansas Children's Hospital (2021–2023); University of Arkansas Medical Center (2021); University of South Alabama (2023)
College of Medicine Administration
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Lyndsay Fisher's research focuses on the identification and management of infectious diseases and neoplasms, particularly in pediatric populations. Her work includes prospective validation studies of predictive models for bloodstream infections in children with cancer, such as the Esbenshade Vanderbilt Models. Fisher has also investigated rare medical conditions, including pneumorrhachis in a pediatric patient with a back injury and a fatal tick-borne disease presenting as an HLH-like syndrome in an infant. Her publications also address the timely administration of antibiotics to febrile neutropenic patients in emergency settings. Fisher has collaborated with researchers at the University of Arkansas for Medical Sciences, including Kevin Bielamowicz, Salim Aljabari, Steven Dahl, and Hannah Wilkins.
Metrics
- h-index: 2
- Publications: 4
- Citations: 17
Positions
-
Physician publications 2021–2023University of Arkansas for Medical Sciences College of Medicine Administration Institutional directory
Selected Publications
-
828: FATAL TICK-BORNE DISEASE IN A VERY YOUNG INFANT: AN UNUSUAL DRIVER OF HLH-LIKE SYNDROME (2023)
-
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer (2023)
-
Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room (2023)
Collaboration Network
Top Collaborators
- Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Similar Researchers
Based on overlapping research topics